
CAS 1629138-41-5
:Formule :C20H31N3O
InChI :InChI=1S/C20H31N3O/c24-20(22-19-9-5-2-6-10-19)23(15-17-7-3-1-4-8-17)16-18-11-13-21-14-12-18/h1,3-4,7-8,18-19,21H,2,5-6,9-16H2,(H,22,24)
Code InChI :LNOPAJNGRAPFKZ-UHFFFAOYSA-N
SMILES :C1CCC(CC1)NC(=O)N(CC2CCNCC2)CC3=CC=CC=C3
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
8 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
SRI-011381
CAS :Formule :C20H31N3ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :329.4796Ref: IN-DA00ASSU
1mg56,00€5mg95,00€10mg113,00€25mg153,00€100mg369,00€250mg717,00€500mg1.024,00€1g1.968,00€SRI-011381
CAS :SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.Formule :C20H31N3ODegré de pureté :98.64%Couleur et forme :SolidMasse moléculaire :329.4796SRI-011381
CAS :1-Benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)ureaFormule :C20H31N3ODegré de pureté :98%Masse moléculaire :329.481-Benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea
CAS :Formule :C20H31N3ODegré de pureté :98%Masse moléculaire :329.488SRI-011381
CAS :SRI-011381 is a novel small molecule inhibitor of the ubiquitin proteasome pathway. It inhibits the degradation of proteins by inhibiting the activity of the ubiquitin proteasome, which is required for protein synthesis. SRI-011381 has been shown to inhibit tumor growth in vivo and in vitro, as well as prevent the development of cancer tissues. This drug also has anti-inflammatory properties and may be useful for treating idiopathic urticaria. SRI-011381 has strong antimicrobial activity against Gram-positive bacteria, such as methicillin resistant Staphylococcus aureus (MRSA) and Bacillus cereus. It also inhibits growth factor β1, which is responsible for proliferation in cells with metabolic disorders.Formule :C20H31N3ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :329.48 g/molRef: 3D-EQC13841
Produit arrêté







